Credit Suisse Group Boosts Danaher Corporation (DHR) Price Target to $96.00

Danaher Corporation (NYSE:DHR) had its price target boosted by Credit Suisse Group from $93.00 to $96.00 in a report issued on Friday. Credit Suisse Group currently has an outperform rating on the conglomerate’s stock.

Several other equities research analysts also recently weighed in on the company. J P Morgan Chase & Co reissued an overweight rating and issued a $95.00 price objective on shares of Danaher Corporation in a report on Friday, September 8th. BidaskClub downgraded Danaher Corporation from a hold rating to a sell rating in a report on Saturday, July 8th. Wells Fargo & Company reissued a market perform rating on shares of Danaher Corporation in a report on Saturday, July 22nd. Citigroup Inc. set a $96.00 price target on Danaher Corporation and gave the stock a buy rating in a research note on Friday, July 21st. Finally, Zacks Investment Research upgraded Danaher Corporation from a hold rating to a buy rating and set a $97.00 price target for the company in a research note on Thursday, October 5th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. Danaher Corporation has an average rating of Buy and a consensus price target of $93.31.

Danaher Corporation (NYSE DHR) opened at 90.79 on Friday. Danaher Corporation has a 52-week low of $76.27 and a 52-week high of $91.64. The firm’s 50-day moving average is $86.59 and its 200-day moving average is $84.29. The stock has a market capitalization of $63.07 billion, a price-to-earnings ratio of 28.98 and a beta of 1.03.

Danaher Corporation (NYSE:DHR) last posted its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.05. The business had revenue of $4.53 billion during the quarter, compared to the consensus estimate of $4.47 billion. Danaher Corporation had a return on equity of 11.48% and a net margin of 13.36%. The company’s revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.87 earnings per share. Analysts predict that Danaher Corporation will post $3.97 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this news story can be accessed at https://transcriptdaily.com/2017/10/23/credit-suisse-group-boosts-danaher-corporation-dhr-price-target-to-96-00.html.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be paid a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.62%. The ex-dividend date is Thursday, September 28th. Danaher Corporation’s payout ratio is currently 16.52%.

In other news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the firm’s stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the transaction, the insider now directly owns 155,520 shares in the company, valued at approximately $12,718,425.60. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider William King sold 43,688 shares of the firm’s stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $82.86, for a total value of $3,619,987.68. Following the completion of the transaction, the insider now owns 45,748 shares in the company, valued at $3,790,679.28. The disclosure for this sale can be found here. 12.20% of the stock is currently owned by company insiders.

Several institutional investors have recently added to or reduced their stakes in the company. Whittier Trust Co. raised its holdings in shares of Danaher Corporation by 2.0% in the 3rd quarter. Whittier Trust Co. now owns 83,958 shares of the conglomerate’s stock worth $7,201,000 after purchasing an additional 1,678 shares during the period. Montecito Bank & Trust raised its holdings in shares of Danaher Corporation by 12.5% in the 3rd quarter. Montecito Bank & Trust now owns 6,028 shares of the conglomerate’s stock worth $517,000 after purchasing an additional 672 shares during the period. Rockefeller Financial Services Inc. raised its holdings in shares of Danaher Corporation by 82.0% in the 3rd quarter. Rockefeller Financial Services Inc. now owns 20,370 shares of the conglomerate’s stock worth $1,747,000 after purchasing an additional 9,177 shares during the period. Bristlecone Advisors LLC raised its holdings in shares of Danaher Corporation by 256.6% in the 3rd quarter. Bristlecone Advisors LLC now owns 12,396 shares of the conglomerate’s stock worth $1,063,000 after purchasing an additional 8,920 shares during the period. Finally, Mountain Pacific Investment Advisers Inc. ID raised its holdings in shares of Danaher Corporation by 0.9% in the 3rd quarter. Mountain Pacific Investment Advisers Inc. ID now owns 377,285 shares of the conglomerate’s stock worth $32,364,000 after purchasing an additional 3,415 shares during the period. Institutional investors own 75.66% of the company’s stock.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Analyst Recommendations for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply